Post-Relapse Survival in Lymphoma Patients (Pts) after Experiencing Therapy Failure Following an Allogeneic Hematopoietic Cell Transplantation (alloHCT)

MLA

Anita D’Souza, et al. “Post-Relapse Survival in Lymphoma Patients (Pts) after Experiencing Therapy Failure Following an Allogeneic Hematopoietic Cell Transplantation (AlloHCT).” Biology of Blood and Marrow Transplantation, vol. 23, Mar. 2017, p. S48. EBSCOhost, https://doi.org/10.1016/j.bbmt.2016.12.097.

APA

Anita D’Souza, Parameswaran Hari, Timothy S. Fenske, Mehdi Hamadani, Marcelo C. Pasquini, Nirav N. Shah, Ariel Kleman, Wael Saber, Dheeraj Kodali, Narendranath Epperla, Michael Craig, & Abraham S. Kanate. (2017). Post-Relapse Survival in Lymphoma Patients (Pts) after Experiencing Therapy Failure Following an Allogeneic Hematopoietic Cell Transplantation (alloHCT). Biology of Blood and Marrow Transplantation, 23, S48. https://doi.org/10.1016/j.bbmt.2016.12.097

Chicago

Anita D’Souza, Parameswaran Hari, Timothy S. Fenske, Mehdi Hamadani, Marcelo C. Pasquini, Nirav N. Shah, Ariel Kleman, et al. 2017. “Post-Relapse Survival in Lymphoma Patients (Pts) after Experiencing Therapy Failure Following an Allogeneic Hematopoietic Cell Transplantation (AlloHCT).” Biology of Blood and Marrow Transplantation 23 (March): S48. doi:10.1016/j.bbmt.2016.12.097.